Non-traditional lipid profiles associated with ischemic stroke not hemorrhagic stroke in hypertensive patients: results from an 8.4 years follow-up study

References

Page 1

	Year	Citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) Scott M. Grundy JAMA Metabolic SyndromeHypertensionSecond ReportPrimary PreventionCardiovascular Disease	1993	27.9K
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia James Shepherd, Stuart M. Cobbe, Ian Ford, New England Journal of Medicine	1995	7.5K
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, New England Journal of Medicine	2008	6.5K
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Peter Sever, Björn Dahlöf, Neil R Poulter, The Lancet ThrombosisHypertensionCardiovascular DiseaseHypertensive PatientsMedicine	2003	3.8K
Rosuvastatin to Prevent Vascular Events in Men and Women With Elevated C-Reactive Protein Paul M. Ridker, Eleanor Danielson, Francisco Antônio Helfenstein Fonseca, Obstetrical & Gynecological Survey Vascular DiseaseElevated C-reactive ProteinUnstable AnginaHyperlipidemiaPharmacotherapy	2009	3.7K
Major Lipids, Apolipoproteins, and Risk of Vascular Disease JAMA	2009	2.7K
Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010 Gonghuan Yang, Yu Wang, Yi‐Xin Zeng, The Lancet	2013	2K
Status of Hypertension in China Zengwu Wang, Zuo Chen, Linfeng Zhang, Circulation	2018	1.8K
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT) JAMA	2002	1.3K
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial Haruo Nakamura, Kikuo Arakawa, Hiroshige Itakura, The Lancet Non-pharmacological InterventionPrimary PreventionPreventive MedicineCardiovascular DiseaseHealth Policy	2006	949

Page 1